Vanguard Capital Wealth Advisors Omeros Corp Transaction History

Vanguard Capital Wealth Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 17, 2019	SELL	$10.72 - $16.73 $130,290 - $203,336	-12,154 Closed	0 $0
Q3 2018 Oct 19, 2018	SELL	$17.73 - $26.69 $10,638 - $16,014	-600 Reduced 4.7%	12,154 $296,000
Q2 2018 Aug 15, 2018	SELL	$10.79 - $24.44 $3,236 - $7,332	-300 Reduced 2.3%	12,754 $231,000
Q1 2018 Apr 25, 2018	SELL	$9.0 - $20.16 $74,700 - $167,328	-8,300 Reduced 38.87%	13,054 $0
Q4 2017 Feb 15, 2018	BUY	$13.26 - $22.86 $283,154 - $488,152	21,354	21,354 $0

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $684M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Vanguard Capital Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Vanguard Capital Wealth Advisors with notifications on news.